Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC, commonly known as MSD, is a leading global healthcare company headquartered in the United States. Founded in 1891, MSD has established a strong presence in various operational regions, including Europe, Asia, and Latin America, focusing on innovative pharmaceuticals, vaccines, and animal health products.
With a commitment to research and development, MSD is renowned for its core offerings, which include groundbreaking treatments in oncology, infectious diseases, and vaccines. The company has achieved significant milestones, such as the development of key therapies that have transformed patient care. Recognised for its robust market position, MSD continues to be a pioneer in the pharmaceutical industry, driven by a mission to improve health outcomes worldwide.
+23 vs industry average
Merck Sharp & Dohme LLC’s score of 61 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Merck Sharp & Dohme LLC?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
Merck Sharp & Dohme LLC's reported carbon emissions
In 2023, Merck Sharp & Dohme LLC reported total carbon emissions of approximately 6.2 trillion kg CO2e. This figure includes Scope 1 emissions of about 718.4 billion kg CO2e, Scope 2 emissions (market-based) of approximately 184.2 billion kg CO2e, and Scope 3 emissions of around 6.2 trillion kg CO2e. The company has set ambitious climate commitments, aiming for carbon neutrality across its operations for Scope 1 and Scope 2 emissions by 2025. Additionally, Merck aims to reduce absolute Scope 1 and Scope 2 greenhouse gas emissions by 46% by 2030, using 2019 as the baseline year. The emissions data is cascaded from its parent company, Merck & Co., Inc., reflecting the company's commitment to sustainability and climate action. These targets align with industry standards and demonstrate Merck's proactive approach to addressing climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Merck Sharp & Dohme LLC’s Climate Goals (2030 & 2050)
4 goals2030
46% reduction in Scope 2
Reduce absolute scope 1 and scope 2 GHG emissions 46% by 2030 from a 2019 base year (including biogenic emissions and removals from bioenerg…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 4 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Merck & Co., Inc.
Carbon Disclosure Project
Inherited from Merck & Co., Inc.
The Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Merck & Co., Inc.
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Merck Sharp & Dohme LLC
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project